Aarti Drugs Limited — Others, 07-03-2025: Action(s) taken or orders passed

Aarti Drugs Limited has received an administrative warning letter from the Securities and Exchange Board of India (SEBI) related to insider trading violations concerning trading activities by certain entities. While no financial impact is expected, the warning highlights lapses in the company's compliance, specifically inadequate efforts to identify immediate relatives of designated persons and inclusion in the Code of Conduct on Prohibition of Insider Trading (PIT). The company will implement measures to enhance compliance and prevent future occurrences. This development may lead to a cautious investor sentiment as the company addresses compliance vulnerabilities.